INSM

Insmed Incorporated

NasdaqGSUSDEQUITY DELAYED

125.77

▲ 0.69 (0.55%)

MARKET · —

Price

Open

125.08

Prev close

125.08

Day high

127.20

Day low

124.82

Volume

1.12M

Market cap

—

P/E (TTM)

—

52W range

90.39 – 212.75

Trailing performance

Price return · vs SPY

Returnvs SPY

+1.64% +3.0%

+17.09% +13.4%

+14.83% +11.7%

-23.73% -34.8%

YTD

-27.74% -40.0%

-2.84% -22.8%

+458.23% +384.1%

— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

128.80

-2.35% from price

SMA 20

118.00

+6.59% from price

SMA 50

110.80

+13.51% from price

SMA 100

119.06

+5.64% from price

SMA 200

144.18

-12.77% from price

EMA 12

124.62

+0.92% from price

EMA 26

119.16

+5.54% from price

EMA 50

116.27

+8.17% from price

RSI (14)

58.3

Neutral

MACD (12,26,9)

5.46

Hist 0.37

ATR (14)

6.91

5.50% of price

Realised vol 30D

90.9%

Annualised

Bollinger upper

146.35

20, 2σ

Bollinger lower

89.64

20, 2σ

50 / 200 cross

Death

110.80 vs 144.18

Trend bias

Below 200

-12.77%

Risk profile

Daily returns · 1Y window

Beta vs SPY

0.48

Less volatile than market

Correlation to SPY

0.10

Largely independent

Realised vol 30D

90.9%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-56.5%

Peak to trough

Max drawdown 5Y

-56.5%

Peak to trough

ATR 14

6.91

5.50% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 125.77

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

INSM · links out to the publisher

Insmed Insider Sold Shares Worth $637,650, According to a Recent SEC Filing MT Newswires · 3d ago Insmed (INSM) Q2 2026 Earnings Call Transcript Motley Fool · 9d ago Insmed Insider Sold Shares Worth $31,964,810, According to a Recent SEC Filing MT Newswires · 10d ago Insmed Insider Sold Shares Worth $3,494,838, According to a Recent SEC Filing MT Newswires · 15d ago Insmed Outlook Strengthens After Q2 Results, RBC Says MT Newswires · 15d ago What Insmed Stock's Premium Is Actually Buying Trefis · 15d ago Has Insmed (INSM) Risen Above Fair Value After Its 3 Year Run? Simply Wall St. · 15d ago Insmed Tops Q2 Earnings Estimates, Stock Soars 34% on Brinsupri Uptake Zacks · 15d ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.